Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127022 · ClinicalTrials.gov registry record · NA
Effect of Maternal Choline Intake on Choline Status and Health Biomarkers During Pregnancy and Lactation
A NA study, sponsored by Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT01127022 is a NA study that has completed, run by Cornell University. The registered enrollment target is 82 participants.
The verdict
NCT01127022, a NA study, has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effect of varied maternal choline intake on maternal/fetal biomarkers of choline status, genomic expression and metabolomic profiling.
Interventions
- DIETARY_SUPPLEMENT choline chloride
- DIETARY_SUPPLEMENT Choline Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01127022
The ClinicalTrials.gov registry entry for NCT01127022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornell University, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which choline chloride is the first listed.
NCT01127022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01127022 about?
NCT01127022 is a clinical study titled "Effect of Maternal Choline Intake on Choline Status and Health Biomarkers During Pregnancy and Lactation". The purpose of this study is to investigate the effect of varied maternal choline intake on maternal/fetal biomarkers of choline status, genomic expression and metabolomic profiling.
What is the current status of trial NCT01127022?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2009-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01127022?
The interventions under investigation include: choline chloride (DIETARY_SUPPLEMENT), Choline Chloride (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01127022?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.